Pharma operations leaders have increased their focus on network risk management, agile and transparent operations, and shaping the workforce of the future in the post-COVID-19 path to recovery. During the COVID-19 pandemic, however, many across the industry have been highly responsive. Industry operations leaders have rallied to enable the supply of key medicines across borders, manage workforce safety, and handle evolving government restrictions all while beginning to prepare for new vaccines and therapeutics. Most companies have put crisis-response command centers in place to appropriately manage and bring stability to an otherwise unstable time.
At the individual company level, we at Seatrack International Group have established a special supply channel under Covid-19 medicines supply and are now more focused on operational, production and expansion of our supply international points to ease interaction with our customers.
Covid-19 Key Products Supply;
heparin
Enoxaparin sodium injection BP 2×0.6ml
Tocilizumab 10 ml
Molnupiravir 200 mg 30 capsules
Tocilizumab 20 ml
Remdesivir Injection 100/150 mg
Favipiravir Tablets 200/400 mg
Enoxaparin Injection 40/60 mg
Heparin Sodium Injection 5000/25000 IU
Methylprednisolone Succinate Injection
Methylprednisolone Acetate Injection
Noradrenaline Injection
Vasopressin Injection
Atracurium Injection
Teicoplanin Injection
Lopinavir and Ritonavir Tablets
Previous
Next
Seatrack International Covid-19 Key Products Supply